{
  "abstract": "Malignant lymphoedema (ML) is a condition characterised by the accumulation of lymphatic fluid due to the obstruction of lymph vessels by cancerous tumours or metastasis. This form of lymphoedema is distinguished by its accelerated onset and progression, manifesting as oedema, pain and cutaneous changes. Its prevalence is particularly notable in cases of breast, head and neck, gynaecological cancers and melanoma. It is estimated that 50% of recurrences of gynaecological cancers develop ML; no specific data on breast cancer are available. While the treatment of this condition is frequently challenging, if left untreated, it can result in severe swelling, pain and serious complications.",
  "authors": [
    {
      "affiliations": [
        "Physical Medicine and Rehabilitation, Hospital Universitario de Toledo, Toledo, Spain"
      ],
      "name": "Ana-Belén Puentes-Gutiérrez"
    },
    {
      "affiliations": [
        "Hospital Universitario de Toledo, Toledo, Spain"
      ],
      "name": "Maria Garcia-Bascones"
    },
    {
      "affiliations": [
        "Hospital General Virgen de la Luz, Cuenca, Spain"
      ],
      "name": "Elena Vaquero-Ramiro"
    },
    {
      "affiliations": [
        "Hospital General La Mancha Centro, Alcázar de San Juan, Spain"
      ],
      "name": "Laura Millan-Casas"
    },
    {
      "affiliations": [
        "Hospital Universitario de Toledo, Toledo, Spain"
      ],
      "name": "Juan-David Cardenas"
    }
  ],
  "title": "Palliative care of malignant lymphoedema",
  "uid": "b9ee5537-7ef8-513e-aad0-de58cce308a4"
}